In various cancer contexts, VD has been shown to engage with VDR and inhibit tumor progression through the PI3K-AKT-mTOR pathway, as observed in Kaposi's sarcoma cells 96 and non-small cell lung cancer 97. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.